von Bergwelt-Baildon MS - Search Results

1

Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.

Becker HJ, Kondo E, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon MS. Becker HJ, et al. Among authors: von bergwelt baildon ms. Eur J Haematol. 2016 Aug;97(2):166-74. doi: 10.1111/ejh.12699. Epub 2015 Dec 10. Eur J Haematol. 2016. PMID: 26561366

2

DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.

Schultze JL, Grabbe S, von Bergwelt-Baildon MS. Schultze JL, et al. Trends Immunol. 2004 Dec;25(12):659-64. doi: 10.1016/j.it.2004.09.016. Trends Immunol. 2004. PMID: 15530836 Review.

3

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.

von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL. von Bergwelt-Baildon M, et al. Blood. 2006 Apr 1;107(7):2786-9. doi: 10.1182/blood-2004-01-0113. Epub 2005 Dec 15. Blood. 2006. PMID: 16357329 Free PMC article.

4

Statins inhibit human APC function: implications for the treatment of GVHD.

Shimabukuro-Vornhagen A, Liebig T, von Bergwelt-Baildon M. Shimabukuro-Vornhagen A, et al. Blood. 2008 Aug 15;112(4):1544-5. doi: 10.1182/blood-2008-04-149609. Blood. 2008. PMID: 18684883 Free article. No abstract available.

5

Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM, Schultze JL, von Bergwelt-Baildon MS. Kondo E, et al. Clin Cancer Res. 2008 Oct 15;14(20):6574-9. doi: 10.1158/1078-0432.CCR-08-0825. Clin Cancer Res. 2008. PMID: 18927298

6

CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.

Kondo E, Gryschok L, Klein-Gonzalez N, Rademacher S, Weihrauch MR, Liebig T, Shimabukuro-Vornhagen A, Kochanek M, Draube A, von Bergwelt-Baildon MS. Kondo E, et al. Clin Exp Immunol. 2009 Feb;155(2):249-56. doi: 10.1111/j.1365-2249.2008.03820.x. Epub 2008 Nov 24. Clin Exp Immunol. 2009. PMID: 19040609 Free PMC article. Review.

7

Using CD40-activated B cells to efficiently identify epitopes of tumor antigens.

Kondo E, Gryschok L, Schultze JL, von Bergwelt-Baildon MS. Kondo E, et al. J Immunother. 2009 Feb-Mar;32(2):157-60. doi: 10.1097/CJI.0b013e31819031a2. J Immunother. 2009. PMID: 19238014

8

The use of statins in hematopoietic stem cell transplantation.

Shimabukuro-Vornhagen A, Glossmann J, Liebig T, Scheid C, von Bergwelt-Baildon M. Shimabukuro-Vornhagen A, et al. Curr Stem Cell Res Ther. 2009 Dec;4(4):260-5. Curr Stem Cell Res Ther. 2009. PMID: 19500062 Review.

9

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

Shimabukuro-Vornhagen A, Kondo E, Liebig T, von Bergwelt-Baildon M. Shimabukuro-Vornhagen A, et al. Blood. 2009 Jul 16;114(3):746-7; author reply 747. doi: 10.1182/blood-2009-03-212886. Blood. 2009. PMID: 19608762 Free article. No abstract available.

10

The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells.

Kondo E, Maecker B, Draube A, Klein-Gonzalez N, Shimabukuro-Vornhagen A, Schultze JL, von Bergwelt-Baildon MS. Kondo E, et al. Int J Cancer. 2009 Nov 15;125(10):2474-8. doi: 10.1002/ijc.24629. Int J Cancer. 2009. PMID: 19681121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters